Caffeine-Associated Cardiac Dysrhythmia During ECT: Report of Three Cases

Area of Science:

• Neurology
• Cardiology
• Pharmacology

Background:

• Caffeine is increasingly used in electroconvulsive therapy (ECT) to prolong seizures.
• Previous reports suggest potential adverse cardiovascular effects.
• The safety profile of caffeine augmentation in ECT requires further investigation.

Purpose of the Study:

• To report cases of severe cardiac dysrhythmia associated with caffeine use in ECT.
• To highlight the risks of caffeine augmentation in specific patient populations.
• To inform clinical practice regarding caffeine use in ECT.

Main Methods:

• Case series reporting three patients who experienced severe cardiac dysrhythmia.
• Review of patient history, focusing on age and pre-existing cardiac conditions.
• Analysis of the temporal relationship between caffeine administration and cardiac events.

Main Results:

• Three elderly patients with prior cardiac illness developed severe cardiac dysrhythmia during ECT with caffeine.
• All adverse events occurred in the presence of caffeine.
• These findings suggest a potential link between caffeine and cardiac complications in vulnerable patients.

Conclusions:

• Non-pharmacologic alternatives for seizure treatment should be considered.
• Thorough cardiac history evaluation is crucial before administering caffeine in ECT.
• Continued patient monitoring is essential when caffeine is used.
• Prospective studies are needed to precisely assess caffeine's risks in patients with cardiac disease.